Edetic acid
- Generic Name
- Edetic acid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H16N2O8
- CAS Number
- 60-00-4
- Unique Ingredient Identifier
- 9G34HU7RV0
- Background
A chelating agent (chelating agents) that sequesters a variety of polyvalent cations. It is used in pharmaceutical manufacturing and as a food additive.
- Indication
For the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults.
- Associated Conditions
- Lead Poisoning, Toxic encephalopathy
- Associated Therapies
- -
EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 20
- Registration Number
- NCT04893577
- Locations
- 🇺🇸
University of Utah MidValley Dermatology, Murray, Utah, United States
Trial to Assess Chelation Therapy (TACT)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2002-08-23
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- Mt. Sinai Medical Center, Miami
- Target Recruit Count
- 1708
- Registration Number
- NCT00044213
- Locations
- 🇨🇦
Saskatoon Chelation Centre, Saskatoon, Saskatchewan, Canada
🇺🇸The Blend Institute, Bradenton, Florida, United States
🇺🇸Innovative Research of West Florida, Clearwater, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath